B of A Securities maintains Underperform rating on Campbell's with new PT of $30.
PorAinvest
jueves, 4 de septiembre de 2025, 2:01 pm ET1 min de lectura
CPB--
The company's earnings have been strong, with Campbell surpassing consensus EPS estimates four times over the last four quarters. However, the stock has underperformed the broader market, with shares down about 24.9% year-to-date compared to the S&P 500's gain of 9.1%. The sustainability of Campbell's stock price movement will depend on management's commentary during the earnings call and future earnings expectations [1].
Analysts have expressed mixed sentiments towards Campbell's stock. While the company's fundamentals are strong, indicated by a high internal diagnostic score of 9.15, technical indicators suggest caution, with a weak score of 3.33. Analyst ratings range from "Strong Sell" to "Neutral," with a performance-weighted rating of 2.79 [3]. Additionally, institutional outflows have been significant, with large funds trending negatively, while retail interest remains high [3].
Institutional investors may be cautious due to recent developments in the food and delivery sectors. DoorDash's expansion and the growing diabetic food market could reshape Campbell's competitive landscape. The global diabetic food market is projected to reach USD 24.86 billion by 2033, presenting an opportunity for Campbell's to adjust its product line [3].
Bank of America Securities has maintained an Underperform rating on Campbell's with a new price target of $30. The rating reflects concerns about the company's earnings outlook and the broader food industry's challenges. The Zacks Rank for Campbell's remains at #5 (Strong Sell), suggesting that the stock is expected to underperform the market in the near future [1].
Investors should closely monitor Campbell's earnings outlook and management's commentary to gauge the stock's future performance. The current consensus EPS estimate is $0.78 for the coming quarter and $2.62 for the current fiscal year. The company's earnings surprise and strong fundamentals may provide some optimism, but technical indicators and analyst ratings suggest caution [1].
References:
[1] https://finance.yahoo.com/news/campbells-cpb-q4-earnings-beat-122501387.html
[2] https://au.finance.yahoo.com/news/campbells-cpb-q4-earnings-beat-122501387.html
[3] https://www.ainvest.com/news/stock-analysis-campbell-outlook-technical-downturn-mixed-fundamentals-analysts-2509/
CPB--
B of A Securities maintains Underperform rating on Campbell's with new PT of $30.
Campbell's Soup Company (CPB) reported its quarterly earnings for the period ended July 2025, delivering a surprise beat on the Zacks Consensus Estimate. The company posted earnings of $0.62 per share, compared to the expected $0.57 per share. This marks a +8.77% earnings surprise, which is a significant improvement over the previous quarter's earnings of $0.73 per share. Revenues for the quarter totaled $2.32 billion, slightly missing the Zacks Consensus Estimate by 0.55% [1].The company's earnings have been strong, with Campbell surpassing consensus EPS estimates four times over the last four quarters. However, the stock has underperformed the broader market, with shares down about 24.9% year-to-date compared to the S&P 500's gain of 9.1%. The sustainability of Campbell's stock price movement will depend on management's commentary during the earnings call and future earnings expectations [1].
Analysts have expressed mixed sentiments towards Campbell's stock. While the company's fundamentals are strong, indicated by a high internal diagnostic score of 9.15, technical indicators suggest caution, with a weak score of 3.33. Analyst ratings range from "Strong Sell" to "Neutral," with a performance-weighted rating of 2.79 [3]. Additionally, institutional outflows have been significant, with large funds trending negatively, while retail interest remains high [3].
Institutional investors may be cautious due to recent developments in the food and delivery sectors. DoorDash's expansion and the growing diabetic food market could reshape Campbell's competitive landscape. The global diabetic food market is projected to reach USD 24.86 billion by 2033, presenting an opportunity for Campbell's to adjust its product line [3].
Bank of America Securities has maintained an Underperform rating on Campbell's with a new price target of $30. The rating reflects concerns about the company's earnings outlook and the broader food industry's challenges. The Zacks Rank for Campbell's remains at #5 (Strong Sell), suggesting that the stock is expected to underperform the market in the near future [1].
Investors should closely monitor Campbell's earnings outlook and management's commentary to gauge the stock's future performance. The current consensus EPS estimate is $0.78 for the coming quarter and $2.62 for the current fiscal year. The company's earnings surprise and strong fundamentals may provide some optimism, but technical indicators and analyst ratings suggest caution [1].
References:
[1] https://finance.yahoo.com/news/campbells-cpb-q4-earnings-beat-122501387.html
[2] https://au.finance.yahoo.com/news/campbells-cpb-q4-earnings-beat-122501387.html
[3] https://www.ainvest.com/news/stock-analysis-campbell-outlook-technical-downturn-mixed-fundamentals-analysts-2509/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios